Felipe Lott, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    msd
    Date added:
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Astrazeneca
    Date added:
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Janssen
    Date added:
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    bayer
    Date added:
    Date updated:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Atsellas
    Date added:
    Date updated:
    06/30/2023
Return to Avanços Globais em Câncer de Bexiga (2023) - Português